Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

William E. Rosa

61 indexed publications match this author name.

ORCID: 0000-0002-0680-8911
OpenAlex: https://openalex.org/A5000784145

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 20 Mechanism of Action 17 Wellbeing 15 Safety 14 Receptor Pharmacology 14 Clinical Trial 11 Observational Study 10 Brain Imaging 9 Review Article 8 Emotional Processing 8 Aging 7 Anxiety 7

Journals

PsyArXiv 11 Journal of psychopharmacology (Oxford, England) 6 Psychedelic medicine (New Rochelle, N.Y.) 3 Scientific reports 3 Psychedelics 2 Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association 2 bioRxiv 2 Psychopharmacology 2

Publication history

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurementPsychedelics · 2026-12-01 Development and Psychometric Validation of the ‘Psychedelic Flourishing Scale’PsyArXiv · 2026-09-17 Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17 A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.The International journal on drug policy · 2026-08-01 Retreat from racism: A psychedelic group experience for racial stress and traumaPsychedelics · 2026-07-30 α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in miceMolecular Psychiatry · 2026-07-07 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-03 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentUniversity of Groningen research database (University of Groningen / Centre for Information Technology) · 2026-06-29 Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapyNatural Product Research · 2026-06-02 Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.Psychedelic medicine (New Rochelle, N.Y.) · 2026-06-01 Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyJoCN Forum · 2026-05-08 Human brain changes after first psilocybin useNature Communications · 2026-05-05 High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.Journal of psychopharmacology (Oxford, England) · 2026-05-01 Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-10 Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.BMJ open · 2026-03-12 Standardization of Psilocybin Dosing in a Natural Product-Based Retreat Setting: A Practical Method for Dose Quantification and Adjustment Across SessionsResearch Square · 2025-11-17 Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.Psychiatry research · 2025-10-01 Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.Expert opinion on emerging drugs · 2025-06-01 FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30 A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-04-01 A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-04-01 Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi.Journal of the American Society for Mass Spectrometry · 2025-03-05 Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-02-01 International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMADrug and Alcohol Dependence · 2025-02-01 From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS).Scientific reports · 2025-01-29 Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study.Scientific reports · 2024-11-21 Expert recommendations for Germany's integration of psychedelic-assisted therapy.BMC medical education · 2024-10-24 Human brain changes after first psilocybin usebioRxiv · 2024-10-14 Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.Psychological medicine · 2024-06-01 Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.Journal of psychopharmacology (Oxford, England) · 2024-05-01 Psychedelics and the 'inner healer': Myth or mechanism?Journal of psychopharmacology (Oxford, England) · 2024-05-01 Development of a digital intervention for psychedelic preparation (DIPP).Scientific reports · 2024-02-19 Palliative care patients' attitudes and openness towards psilocybin-assisted psychotherapy for existential distress.Frontiers in psychiatry · 2024-01-01 Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approachPsyArXiv · 2023-11-22 The entropic heart: Tracking the psychedelic state via heart rate dynamicsbioRxiv · 2023-11-09 Extended difficulties following the use of psychedelic drugs: A mixed methods studyPLoS ONE · 2023-10-23 Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.Psychedelic medicine (New Rochelle, N.Y.) · 2023-09-01 Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’PsyArXiv · 2023-04-28 Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15 A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01 Body mass index (BMI) does not predict responses to psilocybin.Journal of psychopharmacology (Oxford, England) · 2023-01-01 The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-11-01 Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-08-01 From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)PsyArXiv · 2022-07-07 From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)PsyArXiv · 2022-07-07 Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.Neuroscience and biobehavioral reviews · 2022-07-01 A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01 A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01 Psychedelics and health behaviour change.Journal of psychopharmacology (Oxford, England) · 2022-01-01 Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online surveyPsychopharmacology · 2021-11-03 Psilocybin for Depression: The ACE Model ManualPsyArXiv · 2021-07-05 Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-10 Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-10 Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of TreatmentJournal of Humanistic Psychology · 2021-04-23 Trial of Psilocybin versus Escitalopram for Depression.The New England journal of medicine · 2021-04-15 Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)PsyArXiv · 2021-03-24 Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in pharmacology · 2021-01-01 The use of the psychological flexibility model to support psychedelic assisted therapyJournal of Contextual Behavioral Science · 2019-12-13 Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant DepressionJournal of Humanistic Psychology · 2017-06-19 Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The international journal of neuropsychopharmacology · 2016-07-01 Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18

Author directory